Cipla Europe
SpainAll drugs from this manufacturer
-
This medication helps reduce inflammation in the lungs to prevent asthma attacks in people who require regular treatment.
Dosage form: suspension for inhalation in pressurized container
Active substance Dosage fluticasone propionate 125 µg -
This medication helps to reduce inflammation in the lungs to prevent asthma attacks in people who require regular treatment.
Dosage form: suspension for inhalation in pressurized container
Active substance Dosage fluticasone propionate 250 µg -
It is used for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), helping to relax the bronchi to facilitate breathing.
Dosage form: solution for inhalation in pressurized container
Active substance Dosage ipratropium bromide 20 µg -
It is used to help prevent respiratory problems such as asthma, helping to prevent shortness of breath and wheezing.
Dosage form: suspension for inhalation in pressurized container
Active substance Dosage salmeterol xinafoate 36,32 µg fluticasone propionate 125,00 µg -
It is used to help prevent respiratory problems such as asthma, helping to prevent shortness of breath and wheezing.
Dosage form: suspension for inhalation in pressurized container
Active substance Dosage salmeterol xinafoate 36,32 µg fluticasone propionate 250,00 µg -
It is used to speed up muscle recovery after surgery, helping the person to breathe on their own again sooner. It works by binding to the muscle relaxants rocuronium bromide or vecuronium bromide.
Dosage form: solution for injection
Active substance Dosage sugammadex sodium 108,8 mg/ml